Genomtec S.A. (GMT) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.10x
Genomtec S.A. (GMT) has a Cash Flow Reinvestment Rate of 0.10x as of December 2024, reinvesting zł90.00K (capex zł45.00K plus investments zł-45.00K) from operating cash flow of zł925.00K. See Genomtec S.A. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.10x
(Capex + Investments) / Operating CF
Total Reinvested
zł90.00K
Capex + Investments
Operating Cash Flow
zł925.00K
PLN
Capital Expenditures
zł45.00K
PLN
Annual Cash Flow Reinvestment Rate for Genomtec S.A. (None–None)
Year-by-year capital reinvestment analysis for Genomtec S.A.. See Genomtec S.A. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow